Category Archives: Cell Biology

Trinity Biology Professor and Alumni Co-Author Paper Published in International Scientific Journal – Trinity College

Research by Trinity College Professor of Biology Kent Dunlap and two of his former students was published last month in one of the worlds oldest scientific journals, the London-based Proceedings of the Royal Society B.

The paperwhich Dunlap co-authored with research students Josh Corbo 19 and Margarita Vergara 19, along with collaborators from the University of Texas at Arlingtonreports that killifish in Trinidad that live with predators in their environment grow more brain cells than those that face no predators. The study was highlighted recently by the science and technology magazine New Scientist.

The researchers studied the brains of fish that are separated into distinct populations by waterfalls along streams. The killifish living downstream live among predatory fish, while the fish upstream do not, said Corbo, who double-majored in biology and philosophy at Trinity and is now a Cancer Research Training Award (CRTA) Fellow at the National Cancer Institute. Our central question was: how does negative stimulipredationin the environment affect the rate of brain cell proliferation? The implication of our research reaches much farther than the Northern Mountain Range of Trinidad. The topic of how the environment we live in affects our health concerns many disciplines, from public health to sociology. Our research draws more attention to our understanding of the relationship we as organisms have with our environment.

Dunlap first traveled to Trinidad with the colleges Trinity in Trinidad program and found the freshwater killifish to be a good subject for his work on brain cells. The Dana Foundation supported my research and the Trinity in Trinidad program was very helpful with the logistics, said Dunlap, who has previously researched the production of brain cells in electric fish. When Dunlap brought specimens back to campus to study, Corbo and Vergara got to work. They were motivated, engaged students who really took ownership in the lab and were excellent lab scientists, Dunlap said. They were curious and capable and a delight to work with.

Vergara, who completed a major in biology and a minor in Italian at Trinity and is now earning a masters in clinical embryology at the University of Oxford, said that she and Corbo sectioned brain tissues and conducted a procedure called immunohistochemistry to quantify the formation of new brain cells. Professor Dunlap also allowed us to revise and provide constructive feedback for the manuscriptthat was submitted for publication, Vergara said.

Corbo added, It was a great experience to see a paper from start to finish as an undergraduate, as such an experience is usually gained while in graduate school. Corbo spent a summer working in the lab through Trinitys Summer Research Program and now attributes much of his ability as a researcher to the skills he learned as an undergraduate research student. Professor Dunlap emphasized that your research will not matter if you cannot talk about it. Nothing has been truer, Corbo said. During lab meetings, we would have random research presentations for which he would decide who the audience was; it could be a novice, a biology student, or an expert in the field. The task was to present your research in the most clear and concise manner. That was the most important lesson I learned during my time in the lab.

Trinity students have the opportunity to begin research work early in their undergraduate careers and build strong connections with faculty members. Vergara, who first worked in Dunlaps lab as a sophomore, said, I believe that the most valuable benefit of conducting research as an undergraduate is not only the practical skills that you learn along the way, but the relationships that you get to establish with your professor and lab mates. Professor Dunlap also supervised my thesis project, became a real mentor who advised me when I needed to make important career decisions, and taught me lessons that will always stay with me after graduating from Trinity.

For Vergara, the experience of working on research with Dunlap sharpened her problem-solving skills, strengthened her proficiency as an academic writer and critical thinker, and allowed her to develop new technical expertise. More importantly, she said, it allowed me to gain a balance between independence and collaboration. I learned the importance of asking questions, making decisions as a group, and communicating findings. The research assistantship provided me with a solid foundation for the challenges and tasks that I am now undertaking in graduate school.

Read the full paper co-authored by Dunlap and the Trinity alumni in the Proceedings of the Royal Society B here. Proceedings is the Royal Societys flagship biological research journal, dedicated to the worldwide dissemination of high-quality research. It publishes original articles and reviews of outstanding scientific importance and broad general interest. The main criteria for acceptance are that a study is novel and has general significance to biologists.

Read more from the original source:
Trinity Biology Professor and Alumni Co-Author Paper Published in International Scientific Journal - Trinity College

Foundation Supports New Work on Brain-eating Amoeba – UMass News and Media Relations

Evolutionary cell biologist Lillian Fritz-Laylin, biology, recently was granted a three-year, $300,000Smith Family Award for Excellence in Biomedical Researchto support her research on the pathogenesis of the brain-eating amoebaNaegleria fowleri. The amoeba gets inside swimmers noses, crawls up the olfactory nerve and into the brain where they destroy tissue.

As she explains, Although this amoeba has killed 95% of the people its infected, we know almost nothing about it. She and colleagues use the non-pathogenic sister species Naegleria gruberias a practical and safe study organism for understanding the basic biology of these species, in particular, how the cells move.

Fritz-Laylin adds, There are a lot of species of Naegleria, but only one causes disease, so there has been a lot of focus on that, but when treating the disease what really matters is how to kill Naegleria without hurting our own cells. Well be looking into ways to do that. Our human cells use two different polymer systems to move, but these amoeba use only one of them, so that difference could be a target for treatment.

Katrina Velle, a postdoctoral researcher in the Fritz-Laylin lab one of the few to study this organism, she notes will continue to lead the project and conduct much of the planned experimental and genomic work. Using gene manipulation, genomics techniques, treatment with various compounds and inhibitors, they will study how the organisms move, eat, divide and maintain their water balance.

We might be able to interrupt any one of these systems to kill them without hurting the person infected, Fritz-Laylin points out.

Much of her research has been focused on the evolution of cell movement, she notes, explaining that humans and Naeglaria shared a common ancestor about 1.2 billion years ago. The amoeba, which can either crawl or swim at different life cycle stages, evolved movement that looks similar to that of human white blood cells, but the underlying systems are very different; similar functions evolved along different pathways.

Human white blood cells are immune system scavengers that rove through the bloodstream eating invading pathogens. Fritz-Laylin explains, They eat bacteria, so they crawl around to hunt them. If you look in a microscope, Naeglaria move like our white blood cells but they achieve that movement differently.

For 28 years, the Smith Family Foundation has supported full-time faculty biomedical researchers at nonprofit academic, medical or research institutions in Massachusetts, at Brown University or at Yale University. Its mission is to launch the careers of newly independent biomedical researchers with the ultimate goal of achieving medical breakthroughs.

The rest is here:
Foundation Supports New Work on Brain-eating Amoeba - UMass News and Media Relations

Silicon Therapeutics Expands Leadership Team with Key Appointments in Clinical Development and Strategy as well as Computational Physics – Business…

BOSTON--(BUSINESS WIRE)--Silicon Therapeutics today announced three additions to its management team to help lead the company through its next stage of growth. Humphrey Gardner, MD, FCAP has joined the company as Chief Medical Officer; Christopher Borella, PhD, has joined as Vice President, Head of Operations; and Huafeng Xu, PhD, has joined as Chief Technology Officer.

"The appointments of Humphrey and Chris, who bring deep expertise in clinical development and strategy, reflect the progress we have made in building and advancing our oncology pipeline, said Lanny Sun, Silicon Therapeutics Co-founder and CEO. They will play key roles as our lead STING agonist enters clinical trials and our other programs advance towards the clinic. Huafeng will strengthen our leadership in computational physics, bringing over 15 years of experience in methods and theory development.

Dr. Gardner joins Silicon from Evelo Biosciences, where he served as Chief of Medical Oncology and led oncology discovery as well as the IND and clinical development of their first microbial cancer immune therapy. Previously, he served as Vice President of Early Clinical Development in both Infection and in Oncology at AstraZeneca, and as Senior Vice President of Clinical Development at Karyopharm. Prior to these appointments, he led the Oncology Translational Laboratories at Novartis, and various discovery and translational programs at Biogen. Before joining industry, Dr. Gardner was an Assistant Professor of Cell Biology at The Scripps Research Institute. Dr. Gardner obtained his BA in Biochemistry and his MB, BChir, at the University of Cambridge, UK. He did his specialty training in anatomic pathology at the Beth Israel Hospital, Harvard Medical School. He completed his postdoctoral fellowship at the Whitehead Institute in the laboratory of Professor Rudolf Jaenisch. Dr. Gardner has over 100 publications and patents in fields including oncology, neuroscience, rheumatology, and diagnostics.

Dr. Borella joins Silicon Therapeutics from Agios Pharmaceuticals where he was the Head of Early Stage Program Management and Project Leader for their MAT2A franchise. During his 8+ years at Agios, Chris and his team were directly involved in bringing seven drug candidates including two marketed drugs, Tibsovo (ivosidenib) and Idhifa, (enasidenib) forward into the clinic. Prior to Agios Therapeutics, Dr. Borella held project leadership positions at both Proteostasis and Synta Pharmaceuticals. He received his PhD in Medicinal Chemistry from Stony Brook University and was a post-doctoral fellow at Memorial Sloan Kettering Cancer Center.

Dr. Xu joins Silicon Therapeutics after 12 years at D. E. Shaw Research, the leading institution in method and hardware development for molecular simulations, where he played an early role in designing the specialized Anton chip for molecular dynamics simulations, and he led the development of the methods and software for free energy calculations that are now widely used in the pharmaceutical industry. He has also pioneered the application of long-timescale molecular simulations and statistical mechanical theory in revealing fundamental mechanisms of molecular recognition in immunology and virology. Dr. Xu started his career in the biotechnology industry at 3-Dimensional Pharmaceuticals. He earned his Bachelor of Science from Peking University and his M.S. and Ph.D. degrees from Columbia University. He was a visiting postdoctoral scholar in University of California, San Francisco.

About Silicon Therapeutics

Silicon Therapeutics (SiTX) is a physics-driven drug discovery company focused on small molecule therapeutics for cancer that target innate immunity to light the spark within immunologically cold tumors. The companys unique computational physics-based platform can accurately simulate the physical motion and properties of biological targets at atomistic resolution to reveal unique insights into the drug design process. The platform is cohesively integrated with a world-class wet lab including biophysics, chemistry, and biology to enable rapid hypothesis-driven data generation to advance drug discovery projects on targets that have traditionally been thought of as undruggable. The SiTX lead program is a small molecule STING agonist for systemic delivery in I/O that is slated to enter the clinic in mid-2020.

Learn more at http://www.silicontx.com

More here:
Silicon Therapeutics Expands Leadership Team with Key Appointments in Clinical Development and Strategy as well as Computational Physics - Business...

Advanced imaging tips T cell target recognition on its head – Mirage News

A team of leading Australian scientists have published research which transforms existing perceptions of T cell recognition.

T cells represent a key component of our immune system, and play a critical role in protecting us against harmful pathogens like viruses and bacteria, and cancers. The more we understand about how they recognise, interact with and even kill infected or cancer cells moves us closer to developing therapies and treatments for a range of conditions.

In a paper published today in the premier international journal Science, an Australian team of scientists led by Monash University, Hudson Institute of Medical Research, the Australian Research Council Centre of Excellence in Advanced Molecular Imaging and the University of Melbourne at the Doherty Institute, has redefined what we thought we knew about T cell recognition for the past 20 years.

Hudson Institutes Dr Edward Giles (Honorary Clinical Associate in Regulation of Interferon and Innate Signalling) provided valuable clinical contribution towards the study.

It was great to be able to contribute to this ground-breaking work on T cell recognition said Dr Giles.

Through a clinical collaboration, we were able to show this new immune interaction in the gut, and suggest a role in coeliac disease. Coeliac disease is an immune-mediated disease affected up to 1 in 70 Australians, and its only treatment is a lifelong strictly gluten-free diet. This new work opens potential new targets for treatment, as well as a deeper understanding of how the immune system recognises targets in the gut and elsewhere.

In order to interact with other cells in the body, T cells rely on specialised receptors known as T Cell Receptors (TCRs) that recognise virus or bacteria fragments that are bound to specialised molecules called major histocompatibility complex (MHC) or MHC-like. Over the past 20 years, the prevailing view was that TCRs sat atop the MHC and MHC-like molecules for recognition.

The team of scientists characterised a new population within a poorly understood class of T cells called gamma delta T Cells that can recognise an MHC-like molecule known as MR1.

Using a high intensity X-ray beam at the Australian Synchrotron, the scientists obtained a detailed 3D image of the interplay between the gamma delta TCR and MR1 revealing an intriguing result whereby the gamma delta TCR-bound underneath the MHC-like molecule for recognition.

This highly unusual recognition mechanism reshapes our understanding of how TCRs can interact with their target molecules, and represents a major development in the field of T cell biology.

Think of it like a flag attached to a cell. We always thought the T cells were coming along and reading that flag by sitting atop it. We have determined that instead, some T cells can approach and interact with it from underneath, said Dr Jrme Le Nours from Monash Biomedicine Discovery Institute, co-lead author on the paper.

These are the types of fine and important details that can change how we approach future research avenues in T cell biology, said Dr Le Nours.

This is important because T cells are a critical weapon in our immune system, and understanding how they target and interact with cells is crucial to harnessing their power in therapies such as infection and cancer immunotherapy.

Our study shows that MR1 is a new type of molecular target for gamma delta T cells. These cells play a decisive role in immunity to infection and cancer, yet what they respond to is poorly understood. MR1 may be signalling to gamma delta T cells that there is a virus, or cancer cell and triggering these cells to initiate a protective immune response said Dr Nicholas Gherardin from the Doherty Institute, co-lead author on the paper.

Were very excited to follow up these findings in studies that will aim to harness this new biology in disease settings.

The research findings were a culmination of a six-year project that involved collaborative support from Australian scientists, the ARC Centre of Excellence in Advanced Molecular Imaging, the use of the Australian Synchrotron, and funding from the National Health and Medical Research Council and the Australian Research Council.

Excerpt from:
Advanced imaging tips T cell target recognition on its head - Mirage News

New protocol could signal shift in bone regenerative medicine – PR Web

DURHAM, N.C. (PRWEB) January 06, 2020

A new, safe and efficient way to coax stem cells into bone cells is reported in a recently published article from STEM CELLS Translational Medicine (SCTM). The protocol, developed by researchers at the University of Sydney, Australian Research Centre (ARC) for Innovative BioEngineering, could lead to a shift in the treatment of bone regenerative medicine.

Large bone defects and loss due to cancer or trauma can result in scar tissue that impairs the bones ability to repair and regenerate. The current gold standard therapy, autografting, has inherent drawbacks, including limited availability and donor site morbidity. This leaves researchers seeking an alternative source of bone cells and makes bone tissue engineering a growing field with considerable translational potential.

The success of induced pluripotent stem cell (iPSC) technology to reprogram fibroblasts into progenitor cells of various lineages offers an exciting route for tissue repair and regeneration, said Zufu Lu, Ph.D., a member of the University of Sydneys Biomaterials and Tissue Engineering Research Unit and a research associate at the ARC for Innovative BioEngineering. He is a co-lead investigator of the SCTM study, along with Professor Hala Zreiqat, Ph.D., head of the research unit and director of the ARC Training Centre for Innovative BioEngineering.

However, while iPSC technology represents a potentially unlimited source of progenitor cells and allows patients to use their own cells for tissue repair and regeneration thus posing little or no risk of immune rejection the technology has several constraints. Among them are the requirement for complex reprogramming using the Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc). To add to the complexity, specific stimuli are required to direct iPSCs to re-differentiate to progenitor cells of the lineage of interest.

In addition, Dr. Lu said, any remaining iPSCs pose the risk of tumors following implantation.

One potential way around this, as demonstrated by recent studies, is through the direct reprogramming of fibroblasts into bone cells. Fibroblasts are morphologically similar to osteoblasts. Their similar transcriptomic profiles led us to hypothesize that distinct factors produced by osteoblasts may be capable of coaxing fibroblasts to become osteoblast-like cells, Prof. Zreiqat said.

Previous studies aimed at using fibroblasts to produce various cell types relied on the genetic manipulation of one or more transcription regulators. But just as with iPSCs, reprogramming fibroblasts in this manner has its own inherent technical and safety issues. The Lu-Zreiqat team, however, surmised that an approach employing natural factors might just allow better control over reprogramming and improve the safety.

Unlike genetic reprogramming, chemical induction of cell reprogramming is generally rapid and reversible, and is also more amenable to control through factor dosage and/or combinations with other molecules, Dr. Lu explained.

The team initially determined that media conditioned by human osteoblasts can induce reprogramming of human fibroblasts to functional osteoblasts. Next, said Prof. Zreiqat, our proteomic analysis identified a single naturally bioactive protein, insulin growth factor binding protein-7 (IGFBP7), as being significantly elevated in media conditioned with osteoblasts, compared to those with fibroblasts.

This led them to test IGFBP7s ability as a transcription factor. They found it, indeed, successfully induced a switch from fibroblasts to osteoblasts in vitro. They next tested it in a mouse model and once again experienced success when the fibroblasts produced mineralized tissue. The switch was associated with senescence and dependent on autocrine IL-6 signaling.

The approach we describe in our study has significant advantages over other commonly used cell sources including iPSCs and adult mesenchymal stem cells, Dr. Lu and Prof Zreiqat concluded.

Bone tissue engineering is a growing field where cell therapies have considerable translational potential, but current cell-based approaches face limitations, said Anthony Atala, M.D., Editor-in-Chief of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine. The novel observation described in this study could potentially lead to a shift in the current paradigm of bone regenerative medicine.

This study was conducted in collaboration with the Charles Perkins Centre and the Childrens Hospital at Westmead, University of Sydney.

The full article, Reprogramming of human fibroblasts into osteoblasts by insulin-like growth factor binding protein 7, can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/sctm.19-0281.

About STEM CELLS Translational Medicine: STEM CELLS Translational Medicine (SCTM), co-published by AlphaMed Press and Wiley, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices. SCTM is the official journal partner of Regenerative Medicine Foundation.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals: STEM CELLS (http://www.StemCells.com), celebrating its 38th year, is the world's first journal devoted to this fast paced field of research. The Oncologist (http://www.TheOncologist.com), also a monthly peer-reviewed publication, entering its 25th year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

About Regenerative Medicine Foundation (RMF): The non-profit Regenerative Medicine Foundation fosters strategic collaborations to accelerate the development of regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit, honouring leaders through the Stem Cell and Regenerative Medicine Action Awards, and promoting educational initiatives.

Read more from the original source:
New protocol could signal shift in bone regenerative medicine - PR Web

UC Berkeley Researchers Restore Vision in Mice Through Gene Insertion – Gilmore Health News

Blind Mice Regain Vision After Gene Insertion in Trials

Loss of vision is one of the trickier health issues to deal with and is permanent in most cases. But research done at the University of California Berkeley suggests that people who have lost their eyesight might one day be able to see again.

Using a technique described as rather easy, researchers succeeded in helping mice regain their eyesight by inserting a gene into their eyes. The animals were able to detect motion and patterns as well as avoid obstacles within a month of receiving treatment.

Read Also: New Therapy Restores Vision Loss by Calming down Hyperactive Eye Cells

Around one in every 10 persons above the age of 55 suffers from age-related macular degeneration (AMD), according to estimates. Roughly 170 million people around the world have this disorder.

In addition, retinitis pigmentosa affects about 1.7 million people worldwide. Those who have this most-common form of inherited blindness typically become blind by age 40.

The best option currently available to people who have lost their vision is an electronic implant featuring a video camera. This is not only expensive but also does not deliver the finest results.

Researchers in the current study delivered a gene into the eyes of mice with the aid of an inactivated virus. This novel approach showed great promise of potentially being useful in the future to people with vision loss.

You would inject this virus into a persons eye and, a couple months later, theyd be seeing something, said Ehud Isacoff, a professor of molecular and cell biology at UC Berkeley. With neurodegenerative diseases of the retina, often all people try to do is halt or slow further degeneration. But something that restores an image in a few months it is an amazing thing to think about.

The research was reported in Nature Communications.

It is a thorny affair trying to rectify the genetic flaw that results in the degeneration of the retina. This is mainly because there are hundreds of genetic mutations involved. These mutations ensure that the vast majority of light-converting receptor cells in the retina die off.

Read Also: An Artificial Retina to Restore Sight Could Soon Become a Reality

Isacoff and John Flannery, also a professor of molecular and cell biology at UC Berkeley, had tried a variety of complex approaches over the years to restore vision with limited success. One of the techniques involved the insertion of genetically-engineered neurotransmitter receptors and light-sensitive switches into surviving eye cells.

Finally, the research team settled for a simpler approach of inserting a gene.

The scientists turned to the light-sensitive green cone opsins of photoreceptor cells. They delivered the gene for an opsin into the eye with the aid of an adeno-associated virus (AAV), which infects ganglion cells in the eye.

Usually, ganglion cells are not sensitive to light in blind people. But, in this study, they became light-sensitive after the virus moved the gene into them. The cells became able to send signals to the brain, which translates them into sight.

The researchers succeeded in making 90 percent of ganglion cells in mice sensitive to light in their trials. The animals performed comparatively well, visually, as their healthy counterparts as a result.

To the limits that we can test the mice, you cant tell the optogenetically-treated mices behavior from the normal mice without special equipment, said Flannery.

In mice that regained their eyesight, the vision lasted for their entire lifetime, the research team said.

It remains to be seen, however, whether the results can be replicated in humans. Scientists would require many more virus particles to make this possible because the human eye contains way more ganglion cells.

Isacoff and Flannery did admit that some people might doubt whether opsins can function outside their specialized photoreceptor cells. It is thought that opsins would not work elsewhere without transplanting the enzyme system responsible for recharging them.

Read Also: Age-related Close-up Vision Loss- How do I rid myself of reading glasses?

However, Isacoff theorized that an opsin would inevitably link to the retinal ganglion cells signaling system.

The researchers first tried rhodopsin in rods, being more light-sensitive than opsins in cones. This helped mice that were blind due to retinal degeneration to distinguish light from darkness. But rhodopsin failed in other aspects, including image recognition.

Finally, the team found that the green opsin in cones was 10 times more responsive than rhodopsin. It made the mice more sensitive that they could make out letters on an iPad.

The animals were able to make out and explore three-dimensional (3D) objects, a very common natural behavior. This means they could find their way around more easily.

The UC Berkeley team has fashioned a means of boosting viral delivery for possible use in humans. It aims to insert a light sensor into a high proportion of ganglion cells as done in the mice trials. The number of cells will be comparable to the incredibly high pixel count of a camera.

Isacoff and Flannery are trying to raise funds to assess the feasibility of this gene therapy in humans. They hope to be able to try it within three years in people who have lost their sight.

https://www.nature.com/articles/s41467-019-09124-x

WHO Warning! Too Much Time Staring at a Screen Can Make You Nearsighted

Researchers Explain How Opsin 3 Is Related to Pigmentation Disorders

Prolonged Exposure to Blue Light Emitted from Smartphones and Computers Could Speed up Aging

See the original post here:
UC Berkeley Researchers Restore Vision in Mice Through Gene Insertion - Gilmore Health News

Smaller but Still Deadly: New Insights Into the Life of Teenage T. Rex – Gizmodo

A Tyrannosaurus rex skeleton on display at Washington Pavilions Kirby Science Discovery Center in Sioux Falls, San Diego. Image: AP

Tyrannosaurus rex was among the most fearsome carnivores to have ever lived, but this killer still had to endure an adolescent phase. Far from being awkward, however, these teenage titans managed to pack a tremendous punch prior to maturing into full-sized adults, as new research describes.

Unlike their lumbering yet undeniably powerful parents, teenage T. rex were fast and agile, equipped with teeth that were goodfor cutting, not crushing. These juveniles were able to hold their own in a perilous Cretaceous world, before entering into a growth spurt that brought them into adulthood and a new way of life.

Such are the findings of new research published in Scientific Reports, in which paleontologists analyzed a pair of mid-sized T. rex skeletons found during the early 2000s. Known as Jane and Petey, these fossils were unearthed in Carter County, Montana by paleontologists from the Burpee Museum of Natural History in Rockford, Illinois.

Jane and Petey were roughly half the size of an adultT. rex, which could grow to 12 meters (40 feet) in length. Fully mature T. rexwith their 1.5-meter-long (5-foot) headswere basically gigantic chomping machines who used their powerful jaws to crush prey. Needless to say, this impressive bone-snapping ability, at an estimated 8,000 pounds of force, didnt appear until later in life. The new research is important because it shows how juvenile T. rexes survived before they developed this capacity.

Importantly, the new research could also settle a debate caused by the discovery of Jane, Petey, and other apparently mid-sized T. rex skeletons. Some paleontologists argued that these fossils didnt belong to T. rex, but rather a pygmy genus of tyrannosaurid, which they dubbed Nanotyrannus. The evidence presented in the new paper, led by Holly Woodward from the Department of Anatomy and Cell Biology at the Oklahoma State University Center for Health Sciences, likely represents the death knell for the Nanotyrannus theory, which, to be fair, is a fringe theory to begin with.

The reason for this uncertainty and the ongoing debate, however, can be traced to the lack of juvenile dinosaur specimens.

Historically, many museums would collect the biggest, most impressive fossils of a dinosaur species for display and ignore the others, said Woodward in a press release. The problem is that those smaller fossils may be from younger animals. So, for a long while weve had large gaps in our understanding of how dinosaurs grew up, and T. rex is no exception.

Using a technique known as paleohistology, Woodward and her colleagues studied the microscopic structures embedded within the fossilized bones. Analysis of thin slices taken from the femur and tibia conveyed the specimens age, growth rate, and level of maturity.

To me, its always amazing to find that if you have something like a huge fossilized dinosaur bone, its fossilized on the microscopic level as well, said Woodward. And by comparing these fossilized microstructures to similar features found in modern bone, we know they provide clues to metabolism, growth rate, and age.

Results of the analysis showed that Jane and Petey were around 13 to 15 years old when they died, which means they had yet to experience their pre-adult growth spurt; T. rexes reached maturity at around 20 years of age, but they didnt live much beyond 30.

The new research also showed that T. rex exhibited rapid growth rates similar to modern birds and mammals, but their rate of growth was regulated by the availability of food. Variability in their growth, as evidenced by spacings the growth rings of their bones, suggests they grew quickly when food was in abundance and slowly when food was scarce.

This study helps us understand how T. rex went from a tiny baby to enormous adult, Steven Brusatte, a University of Edinburgh paleontologist not involved with the study, told Gizmodo in an email. Not only did they grow super fast, but they could change their growth rates depending on how much food and resources were available. This flexibility helped T. rex so utterly dominate its ecosystem.

And finally, the new research also shows that these pint-sized T. rexes were still a force to be reckoned with. They were sleek, slender, and fleet-footed and had wonderful knife-like teeth, said study co-author Scott Williams from the Museum of the Rockies in a press release. The new research suggests these animals probably dominated their ecosystems at all ages, he said.

Standing a bit taller than a large horse and measuring around 20 feet in length, teenage T. rexes mustve terrorized the Cretaceous landscape. It seems fitting that this iconic dinosaur, even before reaching full maturity, was already plenty deadly.

See original here:
Smaller but Still Deadly: New Insights Into the Life of Teenage T. Rex - Gizmodo

The Advances that Will Shape Life Sciences in the 2020s – The Scientist

The 2010s brought major advancements in every aspect of the life sciences and ushered in an era of collaboration and multidisciplinary approaches. The Scientist spoke with Steven Wiley, a systems biologist at Pacific Northwest National Laboratory and member of TSs editorial board, about what he thinks the recent past indicates about the upcoming decade of research.

Wiley: The next year will be a continuation of the scientific breakthroughs that were present the last couple of years, and whats happened the last couple of years will fundamentally transform the next decade. There are two areas that I think are really posed for an explosive growth, and one is single-cell biology. . . . The second one people know is transformative . . . is CRISPR technologies.

Wiley: Single-cell sequencing, single-cell proteomics, single-cell imagingthese are all part of this new area of single-cell biology which is really going to impact a whole slew of different fields. We'll see a lot of breakthroughs driven by that in the next year, but well see the full impact of this playing out over the next decade.

[Single-cell biology] started [out] driven by single-cell sequencing, and very near on the horizon is going to single-cell proteomics. And then, of course, that complements a lot of the imaging work thats been done, developing a new generation of probes to be able to query whats happening at the single-cell level.

This really brings to the fore the idea that cells in a population are very heterogeneous, and what we see at the population level is a reflection of what the individual cells are doing. And until we understand what the individual cells in a population are doing, we cant deal with issues of, for example, mathematically modeling whats going on in cells.

[Researchers developing] both sequencing technologies and proteomics technology in the last decade have been working on increased sensitivity and speed and precision. This increase in speed and precision and increasingly small sample size has gotten down to a point where now we can look at things like cancer heterogeneity. That is . . . when you treat a cancer you can kill 95 percent of the tumor but theres 5 percent left and that is whats going to come back, and you have a recurrence of the cancer or metastasis. So its the small parts that really cause the problem, and until you can actually understand why those resistant cells are different, youre never going to do things like develop a completely effective cancer treatment.

Now the technology is thereboth sequencing technology and mass spectrometry technologies. It opens up new worlds of what we can look at, and I think thats why this is really being very transformative. Were now at the level where we can look at individual cells. Thats amazing.

Wiley: CRISPR technologieseveryone touts them as a way of editing the genome, which is true. But the true power of that, I believe . . . is the fact that it provides a way of tagging endogenous genes. So for example, you see a number of different papers come out in which people have used CRISPR technologies to insert fluorescent markers into genes. You can look at the dynamics and localization and expression of individual genes and individual cells.

The second thing that CRISPR is really good at is perturbations, being able to turn up genes and down genes, altering the expression of individual genes up and down in a cell with incredible specificity. For example, [with] a genetic disease or in cancer, most of the really significant impactful genetic changes are at the level of increased expression or decreased expression. So the way we think about changing gene expression is: [in] one cell type, the gene is off, [and in] another cell type, the gene is on. But thats not actually true. There are subtle changes in abundance and localization and disposition of individual genes that have enormous regulatory impact on the cells. But weve lacked good tools to [investigate] that.

The ability to manipulate the expression level of genes, to tag them, to make modifications in the individual genes and cells opens up a toolbox of experimental technologies that are just revolutionary.

Editors note: Answers have been edited for length and clarity.

Emma Yasinski is a Florida-based freelance reporter. Follow her on Twitter@EmmaYas24.

See the original post here:
The Advances that Will Shape Life Sciences in the 2020s - The Scientist

Stick-slip dynamics of cell adhesion triggers spontaneous symmetry breaking and directional migration of mesenchymal cells on one-dimensional lines -…

INTRODUCTION

Directional motility is a plastic process (1) that is the fundamental basis of key biological processes in eukaryotes, such as embryonic morphogenesis, leukocyte trafficking in immune surveillance, and tissue regeneration and repair (2, 3, 4). Furthermore, aberrations in signaling pathways regulating cell migration contribute to tumor invasion (5) and metastasis (6). Over the past decades, two main modes of migration have been identified: adhesion-dependent mesenchymal (7) and adhesion-independent amoeboid migration (8). These migration modes differ in the way forces are generated and transduced within the cell. However, the breaking of cell symmetry is a fundamental process at the basis of any migration event (9, 10).

In the absence of external polarity cues, several mechanisms of spontaneous symmetry breaking have been proposed and are based on polarization of cytoskeleton components (11). For instance, gradients or patterns of morphogens can arise because of specific reaction-diffusion patterns within the cell, leading to its polarization (12). More recently, several mechanisms of spontaneous symmetry breaking of the actomyosin system itself have been proposed, on the basis of either actin polymerization (13, 14) or actomyosin contractility (15, 16, 17). However, relating these symmetry breaking events of various components of the cellular cytoskeleton to both cell-substrate forces and cell locomotion remains largely unexplored.

In the specific case of mesenchymal migration, the spatiotemporal sequence of mechanical symmetry breaking remains controversial. Different models are distinguished by the temporal order in which distinct cytoskeleton forces are activated to trigger directional movement (18). Most studies emphasize force generation due to actin polymerization in the cell front as a first step to initiate migration (3, 19, 20). On the contrary, actomyosin IImediated contractility within the cell rear has been identified as a first step to break cell symmetry in keratocytes (21). Thus, determining the spatiotemporal dynamics of cellular forces and morphological events at the initiation of migration is still an open and major question in biology.

To address this question, we developed a single-cell one-dimensional (1D) migration assay based on real-time force imaging, quantitative microscopy, and soft micropatterning to dynamically quantify in parallel mechanical and morphological parameters during spontaneous symmetry breaking. We found that mesenchymal cells confined to thin adhesive one-dimensional (1D) lines had a characteristic spatial force pattern, from which migratory and multipolar force parameters could be extracted in a straightforward and simplified manner. Our analysis demonstrates the critical role of force-mediated adhesion detachment in the rear of the cell. In particular, we show that migration can occur in the absence of a preestablished cytoskeleton polarity. A theoretical model based on the experimentally observed stick-slip motion shows that these patterns are controlled by coupled dynamics of the actomyosin-generated contractility and cell-substrate adhesion dynamics. We show that this coupling induces correlation between cell speed and cell length, which we could observe by analyzing single-cell trajectories of multiple cell lines, confirming the robustness of the proposed stick-slip behavior.

To quantitatively investigate the dynamics of spontaneous symmetry breaking events in cells at the level of both morphological parameters and distribution of interaction forces with the environment, we developed a 1D migration assay (Fig. 1A) that combined time-resolved traction force microscopy (TFM) (22, 23, 24) and soft micropatterning (25).

(A) Polyacrylamide gel (40 kPa) with RPE1 cells (blue, nucleus staining) on top of 2-m micropatterned fibronectin lines (red). (B) Bright-field, actin cytoskeleton, and bead imaging of RPE1 on a 2-m line allowed extracting morphometric and mechanical parameters simultaneously. (C) Time sequence of RPE1 cell migrating on fibronectin lines and (D) its associated stress profile extracted via TFM (dotted white line, cell outline; color-coded stress profile depending on the direction of applied traction forces F: red in and cyan against the direction of migration. Scale bars, 10 m).

Using this bottom-up approach, we followed single epithelial cells [hTERT (human telomerase reverse transcriptase)immortalized retinal pigment epithelial cell line (RPE1)] during the initiation of spontaneous migration and extracted morphometric and mechanical parameters. As expected (26, 27), RPE1 cells plated on patterned 40-kPa polyacrylamide hydrogels adhered to 1D fibronectin lines (2- or 5-m width) within 1 to 2 hours. The cells displayed elongated shapes with long actin fibers oriented parallel to the micropattern and cell axis (Fig. 1B).

In the absence of any external cue, we observed a biphasic motile behavior: symmetric elongation of a static cell (spreading phase) before spontaneously initiated directional movement (migration phase; Fig. 1C). In parallel, tangential stress measurements revealed defined stress compartments at both cell edges due to contractile forces oriented toward the center of the cells (Fig. 1D). Hence, cells behaved as force dipoles, as described previously (14, 28, 29, 30). During the spreading phase, both cell elongation dynamics and force distribution patterns were fully symmetric with respect to the cell center of mass. At the onset of motility, morphological polarization and simultaneous asymmetrical redistribution of forces occurred, characterized by a single defined local stress compartment at the cell front and a substantially widened stress distribution with lower traction stress at the rear (Fig. 2A). This was accompanied by rapid retraction of the cell rear (Fig. 1D).

Current models emphasize the formation of a distinct cell front as the first event when cell migration is initiated (10, 31). In contrast, we observed that cell spreading was qualitatively symmetric on both sides and that symmetry breaking occurred with the sudden retraction of the rear. This led us to hypothesize that contractility builds up in a nonpolarized cell, resulting in a local stress increase at both extremities until adhesions in the prospective rear detach.

To challenge the hypothesis that symmetry breaking does not require preestablished rear-front polarity as previously thought (32, 21), we quantified the coordination between mechanical polarization and morphological events. To first confirm the qualitative observation of anisotropic redistribution of traction forces, we adapted multipolar analyses, classically used in the field of microswimmers (33), to our 1D conditions to quantify the asymmetry of the force distribution. We first projected the stress profile along the micropattern axis to obtain a 1D stress profile, a mechanical footprint of the cell. From that, we computed the variance of positive- and negative-directed traction stress profiles (D+, D), which quantified the spatial distribution of each stress compartment at opposite poles of the cell. The normalized ratio, (D+ D)/(D+ + D) (analogous to the normalized stress quadrupole), quantifies the symmetry of the spatial stress distribution and will be referred to as force asymmetry parameter (Fig. 2A).

(A) Scheme of the force asymmetry analysis: The normalized quadrupole was extracted from the 1D projection of the stress profile of an adherent cell (color-coded stress map and 1D profile depending on the direction of applied traction forces F exerted: red in and cyan against the direction of migration). Dynamic measurements revealed a symmetric spatial force profile during static spreading and an asymmetric distribution during migration phases. Inset: average force asymmetry during static and mobile phases of several cells (n = 10). ****P < 0.0001 (unpaired, two-tailed t test). (B) Cell length and total force correlation: increase during spreading phase and decrease during migration. (C) Referenced kymograph of RPE1 cells stably expressing vinculin-eGFP showing a continuous attachment of the front, while adhesions in the rear detached and reattached during one migration cycle (scale bar, 10 m). Tracking the front, rear, and nucleus position over time could further represent this destabilization of the rear. (D) Deduced scheme of the proposed stick-slip migration mechanism: During nonmotile spreading (stick), the cell builds up a high traction force that eventually will overcome adhesion strength in the perspective rear of the cell. Upon the retraction of the rear, the cell shortens and lowers its mechanical interaction with the substrate to initiate migration (slip). (E) Schematic of the model and parameters as defined in the text. (F) Phase diagram of dynamic behaviors predicted by the model, as a function of the actin turnover rate and phenomenological parameter (arbitrary units). Dashed lines show different values of the maximal contractile force Fmax = . (G) Example of stick-slip dynamics predicted by the model. Dynamical eqs. S2 and S3 are solved numerically with vm = 0.5, vp= 0.5, = 1, = 1, = 1 (arbitrary units). Blue, orange, and brown line show rear, nucleus, and front position over time, respectively. Green line depicts the relative traction force level F.

Nonmigrating cells exhibited a force asymmetry parameter fluctuating around zero, indicating a nonpolarized static phase (Fig. 2A). Consistently, fluctuations in the actin profiles were also observed in static phases (fig. S1). No significant polarization of actin distribution was observed before migration initiation. Nevertheless, upon initiation of each migration step, the force asymmetry parameter displayed a sharp transient peak. This sudden increase corresponded to a widening of the spatial stress distribution in the rear of the cell while the stress pattern at the cell front remained localized to the cell edge. This asymmetry subsequently relaxed, leading to another static phase. Several iterations of such phases were typically observed. Consistently, we found larger values in the amplitude of the asymmetry parameter in moving phases in comparison to the static ones for multiple analyzed cells. Thus, initiation of migration is characterized by a sharp increase of the force asymmetry parameter and can occur in the absence of prior polarization of the actin cytoskeleton.

We subsequently hypothesized that stress builds up and fluctuates during the spreading phase until one end randomly detaches, producing a cell rear. This hypothesis was supported by the evolution of the total traction force, a measure of the strength of the mechanical interaction of the cell with the substrate, quantified via TFM. We observed that, in static phases, cell spreading was associated with an increase of the total traction force. Upon the initiation of migration, the force level dropped by approximately 50% (fig. S2). Notably, this decrease in mechanical interaction was directly correlated with a shortening in cell length due to the sudden retraction of the rear (Fig. 2B and fig. S3). To confirm the role of adhesion detachment, we fluorescently labeled cell-substrate anchor points using vinculinenhanced green fluorescent protein (vin-eGFP) to follow the time evolution of adhesion patches during migration. As previously described (34), adhesion sites at the front of the cell were continuously contacting the substrate, while adhesion sites at the rear followed two distinct phases: attachment (cluster growth) and switching abruptly to detachment (disassembly and sliding of smaller adhesion patches; Fig. 2C). Cell morphology and its polarity features showed similar behavior as after the initial symmetric spreading phase, abrupt retraction of the rear triggered subsequent nuclear translocation. Furthermore, throughout the migration cycle, the trailing edge displayed two distinct phases of motion, while the front continuously moved forward (Fig. 2C). This destabilization of the trailing edge demonstrated the critical role of adhesion detachment in the back of the cell. The observed discontinuous migration is similar to what is known in physics as a stick-slip mechanism (Fig. 2D). During the initial spreading phase, cells elongated symmetrically while increasing their contractile stress (stick). Upon reaching a level of stress that adhesion complexes could no longer sustain, adhesions on one cell edge stochastically detached from the substrate. This led to cell shortening due to retraction of the rear and a decrease in cell-substrate interaction (slip). Recovery of the initial cell length and contractility level occurred during the subsequent stick phase. As a consequence of this stick-slip migration, the propensity of cells to enter migratory phases appeared to crucially depend on (i) contractility and (ii) adhesion properties.

To substantiate this observed stochastic stick-slip behavior, we devised a physical model based on minimal ingredients (see the Supplementary Materials for detailed description). The actin cytoskeleton was described as an active, homogeneous 1D viscoelastic gel (35). We assumed that the cells cytoskeleton was fully unpolarized and that the cell body could be mechanically characterized by an effective stiffness k. This elastic behavior encompasses active (i.e., because of motor activity) and passive contributions of both cytoskeleton and membrane. Adhesion sites were described in the framework of the active gel theory as localized regions at both cell extremities carrying outward pointing actin polarity p and subjected to an active force Fa= p, where is a phenomenological coupling constant, which induced cell expansion. The key ingredient of the model relies on the dynamics of adhesion sites, which was written phenomenologically as p=g(vp)p. Here, models the rate of actin turnover, and g the dynamics of adhesion sites assembly that depends on the local velocity vp = v up over the substrate. g is a priori very asymmetric (Fig. 2E). This accounts for the fact that adhesion assembly is drastically reduced upon edge retraction and mildly affected by edge expansion. The analysis of the model revealed that the actin turnover rate critically controls the dynamics. In particular, at a slow turnover rate (as defined in the Supplementary Materials), the system was found to display a stochastic stick-slip behavior, (which notably differs from classical stick-slip behaviors characterized by deterministic oscillations). Cells were predicted to slowly expand and reach the fixed point of the dynamics where any fluctuation leading to infinitesimal retraction is unstable: One end of the cell therefore retracts before spreading symmetrically again. Last, the model successfully predicts that dynamics are critically controlled by the adhesion turnover rate and the maximal contractile force, as summarized in the phase diagram of Fig. 2F, and reproduces the observed stochastic stick-slip dynamics (Fig. 2G).

Of note, the 1D model that we present here is based on the dynamics of cell edges that extend in opposite directions during spreading. A simple generalization of the model from 1D to higher dimensions would be to consider N-competing protrusions (instead of two in the 1D setting) described by the dynamics introduced above while preserving global force balance. In this case, a similar stochastic stick-slip scenario (force buildup until adhesions rapture) can be expected in 2D or 3D environments; this is left for further works.

To challenge the proposed stochastic stick-slip mechanism, we used optogenetics to disrupt its predicted spatiotemporal sequence. We used NIH-3T3 cells stably expressing a Cry2-CIBN (N-terminal domain of cryptochrome-interacting basic-helix-loop-helix) optogenetic probe to dynamically control the localization of ArhGEF11, an upstream regulator of the master regulator of cell rear retraction, RhoA [from now on referred to as optoGEF_RhoA; (36)]. Upon stimulation with blue light, optoGEF_RhoA dimerizes with the CAAX-anchored protein CIBN, leading to its immediate translocation from the cytoplasm to the membrane where it activates RhoA, triggering asymmetric recruitment of actin and subsequent cell migration away from the photoactivation spot. The initiated movement was characterized by a distinct front-rear polarity that was maintained throughout the whole stimulation cycle. By switching the side of stimulation, actin polarity and direction of movement were inverted (Fig. 3A).

(A) Schematic representation of light-induced Cry2-CIBN dimerization and local RhoA activation due to its close proximity to its upstream regulator optoGEF_RhoA. Bright-field and actin imaging and quantification showed the light-induced migration away from the photoactivation area (blue square), which is characterized by a transient front-rear polarity and actin asymmetry (dashed line, nucleus position at t0). (B) Local and global force response of the light-induced rear and of the whole cell, respectively, showed a transient local contractility increase at the perspective rear followed by a global decrease of the mechanical cell-substrate interaction. (C) Cells stably expressing vinculin-iRFP revealed local adhesion reinforcement within the photostimulated area followed by a subsequent adhesion detachment. Dashed line indicates nucleus position at t0. Scale bar, 10 m. a.u., arbitrary units.

This optogenetic approach combined with quantitative force measurements revealed a RhoA-mediated instantaneous and local increase of traction forces in the zone of activation. This transient and spatially confined force increase was followed by a global decrease of the mechanical interaction of the moving cell with its substrate, as seen on the total traction force (Fig. 3B). This drop was similar to the one observed during spontaneous migration (Fig. 2C), which was attributed to adhesion detachment at the cell rear. To confirm that the same process was at play here, we imaged adhesions by transiently transfecting optogenetic cells with vin-iRFP (infrared fluorescent protein). Upon light-induced RhoA activation, we observed first reinforcement, then detachment and sliding of adhesions (Fig. 3C). As actomyosin contractility was stimulated, adhesions were submitted to an increasing level of stress that first led to vinculin recruitment (positive feedback) (37) but ultimately caused adhesions to dissociate. Hence, local stimulation artificially created the cell rear, triggering the first step of cell translocation (adhesion detachment) as in the case of spontaneous migration.

A key prediction of the stick-slip model is that spontaneous symmetry breaking strongly depends on contractility and adhesiveness. To challenge this prediction and to further investigate the stick-slip migration mechanism illustrated in Fig. 2, we systematically analyzed the main parameters of our theoretical model (cell length, adhesion size, and total traction forces) and correlated them with the migratory parameters of single cells of two distinct cell types exhibiting different motile behaviors. The instantaneous speed of the cell centroid was used as a parameter to represent the migration capacity of single cells. To test the broader applicability of the model, fast-migrating RPE1 (38) cells were compared to fibroblast cells (NIH-3T3) that exhibit slow mesenchymal migration (39).

RPE1 cells exhibited a higher speed compared to NIH-3T3 that mostly remained in a static spreading phase with less frequent retraction phases. Comparing cell morphology and traction force level of both cell types, we observed that NIH-3T3 cells exhibited a longer spreading length associated with a larger mechanical interaction of the cells with their microenvironment (Fig. 4A). This result may appear counterintuitive as larger traction forces should facilitate detachment of adhesions and thus cellular movement. However, in the classical catch-bond model, an increase of force would also induce a stabilization and reinforcement of adhesion sites (40). Consistent with this, NIH-3T3 cells had larger adhesion patches compared to RPE1 cells.

(A) Comparison of instantaneous migration speed, total force, cell length, and individual adhesion size of RPE1 and NIH-3T3 cells. (B) FRAP experiments of adhesions located at one cell edge were modeled with a biexponential fit to extract a fast and slow component representing mobile vinculin within the cytoplasm and slow vinculin bound to adhesions. ROI, region of interest. (C and D) Altering the migratory behavior of RPE1 and NIH-3T3 using 1 M pF573,228 to inhibit and 3 M blebbistatin to trigger migration, respectively. Shown are measured parameters relevant for stick-slip migration: average migration speed, total force, cell length, and individual adhesion size. Statistical significance tested with unpaired two-tailed t test. Scatter plots with means and SD. Box plots from minimum and maximum values with the means and SD. Number n of analyzed cells per condition indicated on the respective graph figures. ****P<0.0001; **P<0.01; ns, not significant.

To analyze adhesion strength in more detail, we quantified adhesion dynamics in both cell types. First, total internal reflection fluorescence microscopy (TIRFm) of vin-eGFP adhesions revealed faster adhesion turnover in RPE1 cells compared to NIH-3T3 fibroblasts (movie S1). To further quantify the difference in adhesion dynamics between both cell types, we performed fluorescence recovery after photobleaching (FRAP) experiments on adhesive patches localized at edges of nonmotile cells. To do so, we specifically chose cells that had well-defined symmetric morphologies, indicating that these cells were unlikely to migrate (stick phase). We were thus able to assure measurements independent of any potential intracellular front-rear polarity effects, which might arise during slip phases, by performing FRAP experiments on random sides for a high number of nonpolarized static cells. These FRAP experiments revealed two time components: a fast one that was related to the diffusion of vinculin molecules within the cytosol and a slow one corresponding to the residence time of immobilized vinculin within the adhesion sites (Fig. 4B). The measured slow and fast component ratios revealed that RPE1 cells displayed a lower fraction of bound vinculin compared to NIH-3T3. Since vinculin binding promotes adhesion stability, our data indicated that RPE1 cells exhibited more labile adhesions, while NIH-3T3 adhesions were expected to sustain higher tension without breaking. These findings are in agreement with the stick-slip model since faster RPE1 cells would undergo fast spreading/retraction cycles (large ), while less motile NIH-3T3 relaxed more slowly to the unstable fixed point (small ). Therefore, the migratory behavior of these two cell types could be explained, in the framework of our stick-slip model, by cells having different levels of adhesiveness and contractility.

To further confirm the validity of this model, we used pharmacological treatments to perturb the balance between adhesiveness and contractility. We used a low dose of blebbistatin (3 M) to decrease contractility (41) in NIH-3T3 fibroblasts and 1 M pF573,228 to stabilize adhesions (42) in RPE1 cells. As both parameters (contractility and adhesion strength) are bidirectionally coupled through positive feedback loops (40, 43, 44), one could not be modulated without affecting the other. Blebbistatin-treated NIH-3T3 cells were more readily able to initiate migration, as shown by the increase of their migration speed (Fig. 4C). They exhibited a decrease of total traction force as expected, but also a shortening of the average cell length, which suggested that these cells can more easily detach their adhesions. The size of adhesion patches decreased significantly upon blebbistatin treatment (Fig. 4C). Hence, by inhibiting contractility, cell adhesiveness was lowered, which facilitated the rear detachment and led to cell shortening and increased motility. In agreement with the stick-slip model, low maximal contractile force corresponded to low cell/substrate interactions, giving rise to reduced cell spreading and therefore smaller cell length and potentially larger speeds (provided that the cytoskeleton is polarized).

On the contrary, stabilizing focal adhesions on RPE1 cells decreased their velocity. It also induced a lengthening of the cells and larger adhesion patches (Fig. 4D) as predicted by our model: Diminishing the turnover rate induces a marked stick-slip behavior, with long spreading phases, and therefore large cell length, and slow speed. The dependence of the stick-slip behavior on the turnover rate and contractility results in inverse correlation between average cell length and migration velocity (Fig. 5A), which was consistently observed in both NIH-3T3 and RPE1 cells. More elongated cells, such as NIH-3T3, were associated with stronger adhesions, as they could spread more without detaching, and hence a lower velocity. When this detachment occurred at an early stage of spreading, corresponding to low stress levels, cells were shorter and exhibited higher migration speeds, as in the case of RPE1.

(A) Experimentally deduced phase diagram using a pharmacological approach to alter the migratory behavior of RPE1 and NIH-3T3 cell (error bars show the SD from the mean). (B) Length-speed relation validated by analyzing several cell types coming from the cell race data (one color used per cell type; gray line, linear fit of all data points). (C) Summary showing how cell contractility, and therefore adhesiveness and cell length, control cellular migration.

Last, we asked whether the stick-slip paradigm would operate also in the presence of additional polarization mechanisms. We used deposited data of single-cell trajectories of various cell types on patterned adhesive 1D lines [First World Cell Race (39)]. For each cell line, both instantaneous cell speed and cell length were extracted and correlated with each other (Fig. 5B). Notably, the negative correlation between cell length and cell speed, consistent with the stick-slip regime, was confirmed for most of cell lines.

Our findings demonstrate that a stochastic stick-slip mechanism, which is intrinsically based on the properties of adhesion dynamics, is a very robust feature of adherent cell migration. In particular, while this mechanism provides a simple scenario of spontaneous symmetry breaking and cell polarization, our results do not exclude that stick-slip behavior might also occur in the presence of other polarization mechanisms.

To summarize, we presented an original 1D migration assay based on a combination of soft micropatterning, force imaging, and optogenetics. Movement of cells was restricted along thin adhesive lines and characterized by a distinctive spatiotemporal force pattern. Because of this, we were able to extract and interpret migratory and force parameters in a simplified and straightforward manner, while, at the same time, partially mimicking relevant physiological conditions of 3D fibrillar migration absent in conventionally performed 2D migration studies (26).

Applying this 1D approach in combination with a theoretical framework, we have uncovered a generic stick-slip mechanism, which complements previous studies. Other studies have proposed distinct symmetry breaking scenarios, which emerge either within the front or rear of a cell, generating a cytoskeletal polarity (and hence force asymmetry) before the initiation of migration (20, 21). In contrast, our proposed mechanism allows cells to spontaneously break their symmetry by stochastically detaching adhesive contacts on one side, resulting in a migratory step in the opposite direction. The main originality of our work is that symmetry breaking can emerge independently of a prior polarity of the actin cytoskeleton, due to instabilities of the mechanochemical coupling of the cell to its environment via adhesion sites. This process is controlled by the interplay of contractile forces and focal adhesion dynamics. Hence, by modifying contractility and adhesiveness of the cell, the rate of such stochastic steps (i.e., the instantaneous speed of cell motion) can be controlled. Although the focus of this paper is on mesenchymal cell migration, we anticipate that amoeboid motility could be understood as an extreme regime of a similar mechanism, in which a high adhesion turnover rate causes cells to remain within a fast-moving slip phase. In addition, we found that stochastic stick-slip is responsible for a negative correlation between cell length and cell speed, which we observed across many cell types, thereby suggesting the relevance and robustness of this mechanism beyond the specific 1D assay and the two main cell types that we analyzed in this paper. In light of our findings, cell length represents a direct readout of cell adhesiveness and thus appears as a straightforward parameter to predict cell migratory behavior.

Our stick-slip model explains the adhesion-dependent initiation of migration with an equal probability for cells to start moving in either one of the two possible directions. Yet, once symmetry was broken, we observed cells exhibiting either oscillatory motion with frequent directional changes or persistent movement in one direction. However, how the first stochastic step can lead to the emergence of persistent migration remains out of the scope of our study. Other mechanisms regulating polarity are likely to be at play after initiation of migration and are expected to bias the direction of movement and/or reinforce persistence once symmetry is broken [e.g., other force-generating cytoskeleton systems like the microtubule network as well as the positioning of its organizing center the centrosome (45, 46)]. Together, stochastic stick-slip appears as a basic mechanism of symmetry breaking for various adherent mammalian cell types, which can coexist with other polarization mechanisms.

The general goal of this study was to unravel a temporal sequence of events by following the evolution of the mechanical cell-substrate interaction during spontaneous symmetry breaking. To do so, we designed an in vitro cell migration assay. Our in vitro approach allowed us to simultaneously extract morphometric and mechanical parameters. To do so, our experimental setup was based on a combination of different techniques: The migration assay that we developed is based on microfabrication of thin adhesive linear tracks on soft substrates and force imaging. This bottom-up approach was used to identify key regulating mechanical parameters during spontaneous symmetry breaking. In addition, we further validated and challenged our findings by using pharmacological treatments and optogenetic approaches and extended our study by screening various cell types.

RPE1 wild type (WT) (provided by L. Blanchoin, Cytomorpholab Grenoble, France and stably transfected with vinculin-eGFP by Y. A. Miroshnikova, Institute of Advanced Biology, France), NIH-3T3 WT (gift by H. Maiato, University of Porto, Portugal and stably transfected with vinculin-eGFP by Y. A. Miroshnikova, Institute of Advanced Biology, France), and NIH-3T3 optoGEF_RhoA (given by M. Coppey, Institute Curie, France) were cultured under standard cell culture conditions (37C, 5% CO2) in Gibco Dulbeccos Modified Eagle Medium/Nutrient Mixture F-12 (DMEM)/F-12 GlutaMAX and Gibco DMEM GlutaMAX (Life Technologies), respectively, containing 10% heat-inactivated fetal bovine serum (Life Technologies) and penicillin/streptomycin (100 g/ml) (Sigma-Aldrich).

Cells were plated on patterned polyacrylamide (PAA) hydrogels at a low density of 6 103 cm2 and allowed to spread for 2 to 4 hours. For life imaging, the medium of NIH-3T3 WT/vin-eGFP/optoGEF_RhoA was replaced by Leibovitzs L-15 medium (Life Technologies).

Fibronectin line patterned PAA hydrogels were microfabricated using the glass technique described by Vignaud et al. (47). In short, 32-mm glass coverslips (VWR) were plasma-treated for 30 s and incubated for 30 min at room temperature (RT) with poly-l-lysinegraftedpolyethylene glycol (0.1 mg/ml, pLL-PEG, SuSoS) diluted in Hepes [10 mM (pH 7.4), Sigma-Aldrich). After washing in deionized phosphate-buffered saline (dPBS, Life Technologies), the pLL-PEGcovered coverslip was placed with the polymer brush facing downward onto the chrome side of a quartz photomask (Toppan) for photolithography treatment (5-min ultraviolet-light exposure, UVO Cleaner Jelight). Subsequently, the coverslip was removed from the mask and coated with fibronectin (20 l/ml) (Sigma-Aldrich) and Alexa Fluor 546conjugated fibrinogen (20 l/ml) (Invitrogen) diluted in dPBS for 30 min at RT. In the meantime, a premix of acrylamide (Sigma-Aldrich), N,N-methylenebis (acrylamide) (Sigma-Aldrich) and dPBS was mixed [ratio for a final Young modulus of 40 kPa described in (48)] and degased for 20 min. After, fluorescent nanobeads (dark red, F-8807 PS Invitrogen; dragon green, FCDG003 Bangs Laboratories) were added to the premix, and the dispersion was sonicated for 5 min (Bandelin Sonorex). To initiate polymerization, 1 l of ammonium persulfate and 1 l of tetramethylethylenediamine were added to 165 l of premix and vortexed. A drop of 47 l was immediately placed onto the protein-coated glass coverslip and covered with a previously silanized glass coverslip. Salinization was facilitated beforehand by treating the glass surface with 100% ethanol (Fluka Analytical) containing 0.0035% (v/v) PlusOne Bind-Silane (GE Healthcare Life Science) and 0.0035% (v/v) acetic acid (Sigma-Aldrich). After 30 min of polymerization at RT, the sandwiched coverslips were emerged in double-distilled water (ddH2O) and separated with a scalpel. The PAA hydrogel patterned with fibronectin attached to the silanized coverslip and was stored in dPBS at 4C for up to 1 week.

After at least 3 hours of cell spreading, either one of the following inhibitors was added: 3 M blebbistatin (Sigma-Aldrich) or 1 M pF573,288 (Sigma-Aldrich). Control samples were treated with 0.025% dimethyl sulfoxide (Sigma-Aldrich).

For static imaging, cells were fixed after two subsequent hours of incubation with the inhibitor. For live imaging, cells were exposed to the inhibitor for up to 16 hours.

RPE1 vin-eGFP and NIH-3T3 vin-eGFP cells were fixed after 5 hours of spreading. First, cells were prepermeabilized using 0.25% Triton X-100 (Sigma-Aldrich) diluted in cytoskeleton buffer [10 mM 2-ethanesulfonic acid (MES, Sigma-Aldrich), 100 mM potassium chloride (KCl, Sigma-Aldrich), and 3.6 mM magnesium chloride hexahydrate (MgCl 6H2O, Sigma-Aldrich), and 1.9 mM aminopolycarboxylic acid (EGTA, Sigma-Aldrich) in ddH2O]. The sample was quickly rinsed with the prepolymerization solution and immediately placed into the fixation buffer [4% paraformaldehyde and 10% (w/v) sucrose (Sigma-Aldrich) in cytoskeleton buffer]. After 15-min fixation at RT, samples were washed once with cytoskeleton buffer and blocked for 30 min at RT with blocking buffer [0.5% bovine serum albumin (Sigma-Aldrich), 0.1% sodium azide (NaN3, Sigma-Aldrich), and 20 mM glycine (Sigma-Aldrich) in dPBS]. For additional staining of filamentous actin (F-actin), samples could be incubated for 30 min at RT with Alexa Fluor 647 phalloidin (Sigma-Aldrich) diluted in blocking buffer (1:1000). The fixed sample was mounted onto a glass slide using Fluoromount-G (Electron Microscopy Sciences) and stored at 4C.

Static adhesion imaging was performed on fixed samples using an inverted confocal microscope (Leica TCS-SP8) using a 40 objective (oil immersion, numerical aperture 1.3). Individual adhesion sizes of different conditions were extracted with Fiji using an approach described previously (49).

For dynamic adhesion imaging, NIH-3T3 vin-eGFP, RPE1 vin-eGFP, or NIH-3T3 optoGEF_RhoA cells were plated on fibronectin line patterned glass substrates to enable TIRFm. We used an inverted microscope (Axiovert 200 M, Zeiss) equipped with a charge-coupled device (CCD) camera (Clara CCD, Andor) and a 488-nm argon laser. Cells were kept at 37C and imaged every minute for at least 1 hour. Adhesion dynamics were quantitatively analyzed plotting a kymograph using Fiji. Blue lightinduced adhesion modification was quantified by measuring the vinculin-iRFP recruitment within the photoactivation area. To do so, the integrated fluorescence intensity was measured per image frame using Fiji.

FRAP experiments were performed on NIH-3T3 vin-eGFP and RPE1 vin-eGFP plated on patterned 40-kPa hydrogels using an inverted confocal spinning disk microscope (Andromeda, TILL-FEI). Each FRAP experiment was performed as follows: prebleach, bleach, and recovery. Images were acquired every 500 ms. First, the signal was monitored over 50 time points before photobleaching (prebleach). Per cell, two adhesive cluster located at the edge of the cell were bleached within two rectangular regions of interest (ROIs) of 7.5 m2 using a 488-nm laser at full power (bleach). Afterward, we followed the fluorescence signal over 100 time points (recovery). After waiting for 5 min, the experiment was repeated twice for the same ROIs within the same cell. The extracted fluorescence signal was fit with a biexponential curve to extract a slow and fast component ratio equivalent to the free vinculin within the cytosol and the vinculin engaged within adhesions, respectively.

Experimentally, force measurements were conducted on cells after 2 to 4 hours of spreading using an inverted microscope (Nikon Ti-E) with a Zyla sCMOS camera (Andor) and a temperature control system set at 37C. Single-cell force measurements were performed using a method described previously (25). Images of fluorescent beads within the stressed and relaxed polyacrylamide substrate were taken before and after detachment of the adherent cell, respectively. The displacement field analysis was done using a homemade algorithm based on the combination of particle image velocimetry and single-particle tracking. After drift correction, bead images were divided into smaller subimages (9.22 m). Cross-correlating corresponding subimages in the stressed and reference images yields the mean displacement over each considered region. After correcting this mean displacement, single-particle tracking was performed in each subimage, leading to displacement measurements of high accuracy and a spatial resolution of 20 nm. The final displacement field was interpolated on a regular grid with 1.15-m spacing. From that, cellular traction forces were computed using Fourier transform traction cytometry with zero-order regularization (28, 50), under the assumption that the substrate is a linear elastic half-space and considering only in-plane displacement and stress (tangential to the substrate). The final traction stress was obtained on a grid with 1.15-m spacing. To estimate the total force exerted by a cell, local stress values multiplied by the unit grid area are summed over the whole cell area. All calculations and image processing were performed with MATLAB.

Cells on lines are analyzed in 1D by projecting and summing all cell-exerted traction on the axis of the line. Typically, the 1D traction exhibit two peaks, one at each cell edge, that are respectively oriented toward the positive and negative directions, forming a contractile dipole. First, small stress values corresponding to noise (less than 10% of the stress peak value) were filtered out. Then, positive- and negative-oriented tractions were considered separately. The first order moment of each traction peak was used to derive the center of mass for each traction peak: xs = ( xTsdx)/( Tsdx), where the sign s is either positive or negative referring to the considered traction direction. Then, the width of each stress peak was evaluated by computing its second-order moment centered on each center of mass, xs, by: Ds = (x xs)2Tsdx/( Tsdx). Last, the asymmetry factor is obtained from the normalized difference between the width of positive- and negative-oriented traction, (D+ D)/(D+ + D). This factor is closely related to the force quadrupole used in other works. It has values between 1 and 1. Its amplitude quantifies the degree of force asymmetry (0 corresponding to a symmetric stress distribution), and its sign indicates the direction of this asymmetry.

In this way, the force asymmetry is evaluated at each time point (one point every minute) on TFM movies of cells on lines. To statistically investigate the force-motion relation, we divided the 4- to 5-hour movies into 30-min intervals. For each time interval, the cell was deemed to be either in a static or a moving phase based on the average velocity of its nucleus. Static phases correspond to velocity slower than 0.1 m/min, while moving phases correspond to velocity higher than 0.3 m/min. The mean asymmetry amplitude was calculated by averaging the force asymmetry factor over each 30-min interval. Since cells motion have equal probability to be directed toward the right or the left, raw asymmetry values are centered around zero. To distinguish noise from motion-induced asymmetry, the final asymmetry amplitude was defined as the raw asymmetry values multiplied by the sign of the cell velocity (averaged over the same interval).

Silicon rhodamine (SiR)actin (Spirochrome) was used to stain F-actin within life cells. Cells were incubated overnight with 100 nM SiR-actin and 10 M verapamil. A Nikon Ti-E inverted microscope was used to image the cytoskeleton structure over several hours.

Actin fluorescence images were analyzed to quantify actin asymmetry using the following procedure: After smoothing, the image was divided at the position of the cell nucleus into two subimages, corresponding to the left and right edges of the cell. The transverse actin distribution width each extremity, Wleft and Wright, were estimated by projecting each subimage onto a line orthogonal to the migration axis and by calculating the centered second-order moment of the resulting profile. Comparing these two widths enabled us to quantify asymmetries in the shape of the actin distribution. The asymmetry factor was defined as: WrightWleftWright+Wleft.

Our Nikon Ti-E inverted, fluorescent microscope was equipped with a digital mirror device (Nikon) to locally control area of illumination with a 460-nm light-emitting diode. NIH-3T3 optoGEF_RhoA cells were plated as described on patterned hydrogels and kept at 37C during all optogenetic experiments. Images were acquired every 15 or 60 s. First, cells were observed before photostimulation for at least 10 min. During the subsequent photoactivation cycle, one side of the cell was locally exposed to 150-ms blue-light pulses every minute over a period of at least 15 min. A relaxation period of at least 15 min was done in between two subsequent photoactivation cycles. We were able to perform bead imaging for TFM and/or actin imaging in parallel with the optogenetic stimulation.

Single-cell tracking and extraction of morphometric parameters (front, rear, and nucleus positions) was performed on time-lapse bright-field images of cells migrating on lines by manually clicking on those structures on each frame. Images acquired in the present work (RPE and NIH cells) have been recorded every 5 min, while data originating from the cell race have an interval of 15 min between frames.

The time traces of the morphometric parameters were analyzed in MATLAB. First, the cell center position (middle of the front and rear positions) was smoothed by convolution with a 15-min flat window. The migration velocity and cell length were calculated over an interval of 30 min. We chose this short interval to capture the instantaneous velocity (knowing that the cell race videos have a temporal resolution of 15 min). Then, these instantaneous velocities (in absolute value) and the cell length were averaged over one time trace corresponding to one cell. Each cell was represented by one data point in the velocity versus length graph depicting different cell types. Videos of PRE1 and NIH-3T3 (with or without inhibitor) had a higher time resolution (one frame every 5 min) but were smoothed, and migration parameters were calculated over the same time interval used for the cell race data.

All data were plotted and statistically analyzed in GraphPad Prism (GraphPad Software, San Diego, CA, USA). To test the significance in between data, we performed two-tailed Students t tests. Error bars on graphs represent the SD. If a linear fit was applied, GraphPad Prism computed it with a confidence interval of 95%.

Acknowledgments: We thank M. Piel and P. Maiuri for valuable discussions and sharing the cell race data with us. We also thank T. Boudou and M. Thry for critical discussions, J. Bernard for technical assistance, and members of the MOTIV team at LiPhy for support. We thank L. Blanchoins Cytomorpholab in Grenoble for providing us RPE1 cells and H. Maiato from the University of Porto for providing us with NIH-3T3 cells. Furthermore, we want to thank A. Kyumurkov at the Institute of Advanced Biology in Grenoble for assisting with adhesion imaging. Funding: This work was supported by Nanoscience Fondation (M.B.), the ARC Fondation (M.B.), and the grant ANR-17-CE30-0032-01 of the French Agence Nationale de la Recherche. This work has been partially supported by the LabeX Tec 21 (Investissements dAvenir: grant agreement no. ANR-11-LABX-0030). Author contributions: K.H. performed experiments and analyzed the data. S.D. performed optogenetic experiments on vinculin-iRFPtransfected cells. L.V. designed the optogenetic cell line in M.C.s laboratory. Y.A.M. designed the vinculin-eGFP RPE1 and NIH-3T3 cells in C.A.-R.s laboratory. C.F. provided insights on the FRAP experiments and performed the related data analysis. R.V. developed the theoretical framework. M.B. supervised the research. All authors contributed to writing the paper. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.

See more here:
Stick-slip dynamics of cell adhesion triggers spontaneous symmetry breaking and directional migration of mesenchymal cells on one-dimensional lines -...

Lonza and Allevi to collaborate on advancement of bioprinting capabilities – ChemEngOnline

By Mary Page Bailey | January 2, 2020

Lonza Group (Basel, Switzerland; http://www.lonza.com) and Allevi (Philadelphia, Pa.; http://www.allevi3d.com) are collaborating to bring the elements needed for 3D bioprinting together. Combining Lonzas primary cells and media with Allevis 3D bioprinters and bioink production capabilities will empower researchers with the tools needed for plug-and-play bioprinting.

Allevi is dedicated to providing high-quality materials for every step of the 3D bioprinting workflow, making it easy to design, engineer, and manufacture 3D tissues. Their 3D bioprinters and bioinks are used by leading researchers globally in research drug discovery and tissue engineering.

Lonza Biosciences, a global leader in cell biology solutions, offers a broad range of high-quality human-derived primary cells, stem cells and supporting culture media that are ideally suited for 3D cell culture and 3D bioprinting.

3D bioprinting is a promising technology for engineering of complex 3D tissues needed in many areas of in vitro drug discovery research. High-quality cells are the essential building block for creating 3D bioprinting constructs and can be printed in physiological relevant patterns using this technology.

Lonza collaborates with selected providers of 3D-printing technology to bring the best cell and media tools to 3D bioprinting applications. Allevi customers will now have access to Lonza primary cells and media for use in Allevis protocols for 3D bioprinting.

View post:
Lonza and Allevi to collaborate on advancement of bioprinting capabilities - ChemEngOnline